NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity
NeuroBo Pharmaceuticals在评估Da-1726治疗肥胖的1期临床试验中给首位患者服药
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity
NeuroBo Pharmaceuticals在评估Da-1726治疗肥胖的1期临床试验中给首位患者服药
使用浏览器的分享功能,分享给你的好友吧